These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 4880275)
1. [Antinuclear and perinuclear atibodies in rheumatology. Immunofluorescence studies]. Marmont A; Damasio E G Mal Infett Parassit; 1968 Jan; 20(1):124-32. PubMed ID: 4880275 [No Abstract] [Full Text] [Related]
2. [Our experience in the study of nuclear and antinuclear constituant antibodies in rheumatology]. Kahn MF; Dryll A; de Seze S J Belge Rhumatol Med Phys; 1967; 22(4):217-30. PubMed ID: 4185873 [No Abstract] [Full Text] [Related]
3. Update on autoantibodies to intracellular antigens in systemic rheumatic diseases. Nakamura RM; Tan EM Clin Lab Med; 1992 Mar; 12(1):1-23. PubMed ID: 1563236 [TBL] [Abstract][Full Text] [Related]
4. [Immunological advances in rheumatology]. Astorga G Rev Med Chil; 1968 Feb; 96(2):103-10. PubMed ID: 4180981 [No Abstract] [Full Text] [Related]
5. [Routine immunofluorescence studies for demonstration of antinuclear factors]. Hiemann D Z Gesamte Inn Med; 1969 May; 24(10):150-1. PubMed ID: 4185287 [No Abstract] [Full Text] [Related]
6. The comet pattern of nuclear immunofluorescence. Johnson GD; Smith ME; Holborow EJ Clin Exp Immunol; 1972 Mar; 10(3):463-8. PubMed ID: 4113676 [TBL] [Abstract][Full Text] [Related]
7. [Antinuclear factors. Clinical and humoral correlations; diagnostic importance]. Purice S; Gheorghiu M; Ghelerter L; Drăgoi T Med Interna (Bucur); 1969 Oct; 21(10):1205-40. PubMed ID: 4189145 [No Abstract] [Full Text] [Related]
8. [Contribution of immunology to rheumatology]. Serre H Lille Med; 1977; 22(6):391-8. PubMed ID: 302379 [No Abstract] [Full Text] [Related]
15. [Detection of antinuclear factors in rheumatic diseases]. Ménard HA; Myhal D; Camerlain M; Lussier A Union Med Can; 1974 Apr; 103(4):722-6. PubMed ID: 4601283 [No Abstract] [Full Text] [Related]
16. [Antinuclear antibodies in disseminated lupus erythematosus and other connective tissue diseases]. Velasco M; Losada M; Losada A; Ramirez G Rev Med Chil; 1968 Aug; 96(8):517-21. PubMed ID: 4915546 [No Abstract] [Full Text] [Related]
17. Heterogeneity of antinucleolar antibody and IgE antinuclear antibody in patients with systemic rheumatic diseases. Miyawaki S; Ritchie RF J Immunol; 1974 Oct; 113(4):1346-52. PubMed ID: 4606613 [No Abstract] [Full Text] [Related]
18. [Serum antinuclear antibodies (in patients with visceral erythematodes, rheumatoid arthritis, progressive systemic sclerosis and discoid erythematodes)]. Horvat Z Acta Med Iugosl; 1970; 24(3):229-40. PubMed ID: 4928076 [No Abstract] [Full Text] [Related]
19. [Routine immunofluorescence examinations for the demonstration of antinuclear factors]. Hiemann D Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:150-1. PubMed ID: 4918616 [No Abstract] [Full Text] [Related]
20. Smoking as a trigger for inflammatory rheumatic diseases. Klareskog L; Padyukov L; Alfredsson L Curr Opin Rheumatol; 2007 Jan; 19(1):49-54. PubMed ID: 17143096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]